Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Blood glucose abnormal? 445 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 445 reports of Blood glucose abnormal have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 1.2% of all adverse event reports for EMPAGLIFLOZIN.

445
Reports of Blood glucose abnormal with EMPAGLIFLOZIN
1.2%
of all EMPAGLIFLOZIN reports
1
Deaths
81
Hospitalizations

How Dangerous Is Blood glucose abnormal From EMPAGLIFLOZIN?

Of the 445 reports, 1 (0.2%) resulted in death, 81 (18.2%) required hospitalization, and 25 (5.6%) were considered life-threatening.

Is Blood glucose abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 445 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Blood glucose abnormal?

INSULIN GLARGINE (2,463) INSULIN LISPRO (2,460) DULAGLUTIDE (912) INSULIN HUMAN (900) METFORMIN (563) EXENATIDE (556) SITAGLIPTIN (334) ADALIMUMAB (285) DEVICE (269) TIRZEPATIDE (267)

Which EMPAGLIFLOZIN Alternatives Have Lower Blood glucose abnormal Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Blood glucose abnormal Reports All Drugs Causing Blood glucose abnormal EMPAGLIFLOZIN Demographics